Our Key Takeaways from Gartner® Hype Cycle™ for U.S. Healthcare Payers, 2024 Report
The healthcare industry is continuously evolving and with technological advancements, payers seek innovative ways to optimize operations, reduce costs, and […]
Inovaare listed as a representative vendor in the Gartner® Hype Cycle™ for Healthcare Payers, 2024
The healthcare industry is continuously evolving and with technological advancements, payers seek innovative ways to optimize operations, reduce costs, and […]
On April 15, 2022, the Centers for Medicare & Medicaid Services (CMS) released potential fraud, waste and abuse (FWA) trending
The Centers for Medicare & Medicaid Services (CMS) has added another category of drugs—immunosuppressants—to their national audits in collaboration with
Payment integrity and provider relations are two critical pillars of a well-functioning healthcare system. When effectively managed, they can lead
Starting January 2024, the Medicare Parts C and D Oversight and Enforcement Group of the Centers for Medicare & Medicaid
The Prescription Drug Program, commonly known as Medicare Part D, is undergoing significant transformations in 2025 due to the Inflation
Summary of the HPMS Memo Generated by USHER (Inovaare’s AI-powered Compliance Assistant) The Centers for Medicare and Medicaid Services (CMS)
In recent news, the healthcare industry has been abuzz with significant developments that carry vital lessons for Medicare Advantage plans,
In recent news, the healthcare industry has been abuzz with significant developments that carry vital lessons for Medicare Advantage health
The Annual Election Period (AEP) has ended. Before the Medicare Advantage Open Enrollment Period (MA OEP)[1] begins on January 1, 2024,